The pharmacology of stuttering: a critical review

The author critically examines the limited world literature on pharmacologic treatments of stuttering. The literature on stuttering and drugs was identified by means of two computer-assisted searches. A great variety of pharmacologic agents have been used to treat stuttering, reflecting the many the...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of psychiatry Vol. 148; no. 10; p. 1309
Main Author Brady, J P
Format Journal Article
LanguageEnglish
Published United States 01.10.1991
Subjects
Antipsychotic Agents - therapeutic use
Benzodiazepines - therapeutic use
Calcium Channel Blockers - therapeutic use
Haloperidol - therapeutic use
Humans
Parasympathomimetics - therapeutic use
Research Design - standards
Stuttering - drug therapy
Verapamil - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:The author critically examines the limited world literature on pharmacologic treatments of stuttering. The literature on stuttering and drugs was identified by means of two computer-assisted searches. A great variety of pharmacologic agents have been used to treat stuttering, reflecting the many theories about the origin and nature of the disorder. In some instances new hypotheses about the nature of stuttering have followed the chance discovery of agents having some efficacy. Few studies have used adequate experimental designs. Promising avenues of research, both for the treatment of stuttering and for exploring its nature, include the use of calcium channel blocking agents and cholinergic drugs.
ISSN:0002-953X
DOI:10.1176/ajp.148.10.1309